Inventor
ABUMRAD NAJI
US19 patents
⚠️ This page may combine multiple inventors who share the name “ABUMRAD NAJI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
METABOLIC TECH INC
12 patentsUS10201551B2Feb 12, 2019
Nutritional intervention for improving muscular function and strength
METABOLIC TECH INC6 citations82
US9707241B2Jul 18, 2017
Nutritional intervention for improving muscular function and strength
METABOLIC TECH INC5 citations82
US9539224B2Jan 10, 2017
Nutritional intervention for improving muscular function and strength
METABOLIC TECH INC7 citations82
US11406609B2Aug 9, 2022
Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy
METABOLIC TECH INC2 citations72
US10213399B2Feb 26, 2019
Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy
METABOLIC TECH INC3 citations72
US10682363B2Jun 16, 2020
Nutritional intervention for improving muscular function and strength
METABOLIC TECH INC2 citations71
US11547713B2Jan 10, 2023
Nutritional intervention for improving muscular function and strength
METABOLIC TECH INC0 citations61
US11173167B2Nov 16, 2021
Nutritional intervention for improving muscular function and strength
METABOLIC TECH INC1 citations61
US12208073B2Jan 28, 2025
Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma
METABOLIC TECH INC0 citations56
US10772856B2Sep 15, 2020
Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for decreasing fat mass
METABOLIC TECH INC0 citations51
US9770424B2Sep 26, 2017
Nutritional intervention for improving muscular function and strength
METABOLIC TECH INC1 citations51
US10758504B2Sep 1, 2020
Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma
METABOLIC TECH INC0 citations45
MTI BIOTECH INC
2 patentsUS12435025B2Oct 7, 2025
Triphenylphosphonium-tethered salicylamine derivatives
MTI BIOTECH INC0 citations56
US12383515B2Aug 12, 2025
Compositions and methods of use of γ-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (NAFLD), NASH, ALD or conditions related to the liver
MTI BIOTECH INC0 citations56